Anna Tobiasch: Should Fibrinogen and FXIII Be Restored Together After Severe Haemodilution?
Anna Tobiasch, Translational Scientist at Tirol Kliniken GmBH, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in Thrombosis Research, adding:
“This project started with a simple question: if fibrinogen and FXIII decline together during severe haemodilution, should we also think about restoring them together?
Beyond the specific findings, this work highlights an idea that continues to fascinate me: haemostasis is not determined by isolated factors, but by their interactions and the emergent properties of the resulting clot.
Many thanks to everyone who contributed to the study and to the volunteers who participated.”
Title: Defining a fibrinogen-to-factor XIII replacement ratio in an in-vitro model of dilutional coagulopathy
Authors: Cristina Alomar-Dominguez, Marie Therese Bauer, Dietmar Fries, Ludwig Deinhart, Jennifer Gebetsberger, Mirjam Bachler, Johannes Bosch, Wolfgang Schobersberger, Martin Hermann, Christian Irsara, Luca Brunelli, Anna Katharina Tobiasch
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 7, 2026, 16:12Amr Mohamed: Common Types of Anemia
-
Jun 7, 2026, 15:50Venkateshwarlu Bairi: AVEVA Hyderabad Supports Children Living with Thalassemia and Sickle Cell Conditions
-
Jun 7, 2026, 15:48José Antonio García Erce: Hemochromatosis and Blood Donation
-
Jun 7, 2026, 15:29Marc Scherlinger: Uncovering the Immuno-Inflammatory Functions of Platelets at EULAR 2026
-
Jun 7, 2026, 15:18Huyen Nguyen: Highlights from the NCCN Cancer-Associated Venous Thromboembolic Disease Guidelines
-
Jun 7, 2026, 14:35Erica Wood: WHO Launches Landmark Action Framework to Secure Safe and Equitable Blood Supply Worldwide
-
Jun 7, 2026, 14:27Jorge Lima: Amniotic Fluid Embolism and Its Impact on Maternal and Perinatal Outcomes
-
Jun 7, 2026, 14:20Utsab Raj Panta: Navigating the A–E Classification in Acute Pulmonary Embolism
-
Jun 7, 2026, 14:19Ming Y Lim: The Burden and Impact of Bleeding in Newly Diagnosed Cancer Patients